UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria

Leukemia research, 2022-05, Vol.116, p.106836-106836, Article 106836

2022

Volltextzugriff (PDF)

P728: GENE EXPRESSION PROFILE REVELS T‐LYMPHOCYTES ACTIVATION THROUGH CELL CYCLE PROGRESSION AND MITOCHONDRIAL METABOLISM REGULATION IN MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) AFTER LENALIDOMIDE TREATMENT

HemaSphere, 2022-06, Vol.6, p.623-624

2022

Volltextzugriff (PDF)

Síndromes mielodisplásicos

Medicine - programa de formación médica continuada acreditado, 2016-11, Vol.12 (21), p.1224-1234

2016

Volltextzugriff (PDF)

Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients

Leukemia research, 2017-04, Vol.55, p.S117-S117

2017

Volltextzugriff (PDF)

Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries

Leukemia research, 2017-04, Vol.55, p.S61-S63

2017

Volltextzugriff (PDF)

Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence

Leukemia research, 2017-04, Vol.55, p.S52-S52

2017

Volltextzugriff (PDF)

Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation

Leukemia research, 2017-04, Vol.55, p.S27-S29

2017

Volltextzugriff (PDF)

308 HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY

Leukemia research, 2015-04, Vol.39, p.S153-S153

2015

Volltextzugriff (PDF)

Top‐level sport in athletes with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4), p.e391-e393

2017

Volltextzugriff (PDF)

Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): UMBRELLA PROJECT: UNIFIED PLATFORM FOR A BETTER INTEGRAL EVALUATION OF MYELODYSPLASTIC SYNDROMES IN SPAIN

Leukemia research, 2023-05, Vol.128, p.107156, Article 107156

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW CYTOKINES AND CHEMOKINES CONCENTRATIONS IN MYELODISPLASTIC NEOPLASMS

Leukemia research, 2023-05, Vol.128, p.107210, Article 107210

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW MICROENVIRONMENT CHANGES IN MYELODYSPLASTIC NEOPLASMS AND ITS RELATIONSHIP WITH CLONAL HEMATOPOIESIS

Leukemia research, 2023-05, Vol.128, p.107209, Article 107209

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SEX DETERMINES DIFFERENTIAL GENOMIC PROFILES IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) INVOLVING UNDERREPRESENTATION OF SRSF2 GENE MUTATION

Leukemia research, 2023-05, Vol.128, p.107188, Article 107188

2023

Volltextzugriff (PDF)

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: GENOMIC DETERMINANTS OF DYSMYELOPOIESIS AND EVALUATION OF ITS PROGNOSTIC IMPACT IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

Leukemia research, 2023-05, Vol.128, p.107231, Article 107231

2023

Volltextzugriff (PDF)

Topic: AS07-Singular Entities/Subtypes/AS07e-Chronic myelomonocytic leukemia and overlap syndromes (MDS/MPN): GENOMIC AND TRANSCRIPTOMIC CHARACTERIZATION OF MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS

Leukemia research, 2023-05, Vol.128, p.107253, Article 107253

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: TP53 ALLELIC STATE DID NOT INFLUENCE THE PROGNOSIS IN MYELODYSPLASTIC SYNDROMES (MDS) WITH 5Q DELETION

Leukemia research, 2023-05, Vol.128, p.107187, Article 107187

2023

Volltextzugriff (PDF)

CHARACTERIZATION OF TRANSCRIPTIONAL ALTERATIONS LEADING TO ABERRANT MYELOID DIFFERENTIATION IN MYELODYSPLASTIC SYNDROMES

Leukemia research, 2023-05, Vol.128, p.107123, Article 107123

2023

Volltextzugriff (PDF)

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: CLINICAL AND CARDIOVASCULAR RISK ASSESSMENT OF SUBJECTS WITH JAK2-V617F CLONAL HEMATOPOIESIS

Leukemia research, 2023-05, Vol.128, p.107240, Article 107240

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICAL TRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?

Leukemia research, 2023-05, Vol.128, p.107180, Article 107180

2023

Volltextzugriff (PDF)

98 - Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries

Leukemia research, 2017-04, Vol.55, p.S61-S63

2017

Volltextzugriff (PDF)

196 - Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients

Leukemia research, 2017-04, Vol.55, p.S117-S117

2017

Volltextzugriff (PDF)

41 - Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation

Leukemia research, 2017-04, Vol.55, p.S27-S29

2017

Volltextzugriff (PDF)

81 - Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence

Leukemia research, 2017-04, Vol.55, p.S52-S52

2017

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)

Sprache

Englisch
(46)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Hematology
(7)
Human Health Sciences
(5)
Humans
(5)
Sciences De La Santé Humaine
(5)
Hématologie
(4)
Animals
(3)
Carcinoma - Therapy
(3)
Gene Therapy
(3)
Male
(3)
Oncology
(3)
Peritoneal Carcinomatosis
(3)
Peritoneal Neoplasms - Therapy
(3)
Rats
(3)
Adult
(2)
Antiviral Agents - Therapeutic Use
(2)
Azacitidine
(2)
Biological And Medical Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria

P728: GENE EXPRESSION PROFILE REVELS T‐LYMPHOCYTES ACTIVATION THROUGH CELL CYCLE PROGRESSION AND MITOCHONDRIAL METABOLISM REGULATION IN MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) AFTER LENALIDOMIDE TREATMENT

Síndromes mielodisplásicos

Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients

Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries

Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence

Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation

308 HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY

Top‐level sport in athletes with severe haemophilia A

Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia

Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): UMBRELLA PROJECT: UNIFIED PLATFORM FOR A BETTER INTEGRAL EVALUATION OF MYELODYSPLASTIC SYNDROMES IN SPAIN

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW CYTOKINES AND CHEMOKINES CONCENTRATIONS IN MYELODISPLASTIC NEOPLASMS

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW MICROENVIRONMENT CHANGES IN MYELODYSPLASTIC NEOPLASMS AND ITS RELATIONSHIP WITH CLONAL HEMATOPOIESIS

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SEX DETERMINES DIFFERENTIAL GENOMIC PROFILES IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) INVOLVING UNDERREPRESENTATION OF SRSF2 GENE MUTATION

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: GENOMIC DETERMINANTS OF DYSMYELOPOIESIS AND EVALUATION OF ITS PROGNOSTIC IMPACT IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

Topic: AS07-Singular Entities/Subtypes/AS07e-Chronic myelomonocytic leukemia and overlap syndromes (MDS/MPN): GENOMIC AND TRANSCRIPTOMIC CHARACTERIZATION OF MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: TP53 ALLELIC STATE DID NOT INFLUENCE THE PROGNOSIS IN MYELODYSPLASTIC SYNDROMES (MDS) WITH 5Q DELETION

CHARACTERIZATION OF TRANSCRIPTIONAL ALTERATIONS LEADING TO ABERRANT MYELOID DIFFERENTIATION IN MYELODYSPLASTIC SYNDROMES

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: CLINICAL AND CARDIOVASCULAR RISK ASSESSMENT OF SUBJECTS WITH JAK2-V617F CLONAL HEMATOPOIESIS

Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICAL TRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?

98 - Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries

196 - Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients

41 - Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation

81 - Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence

MUTATIONS ON COHESIN COMPLEX ARE ASSOCIATED TO A POOR PROGNOSIS IN LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: PF533

Suchergebnisse filtern